Corbus Pharmaceuticals (CRBP) announced that data from its US and UK conducted first-in-human dose escalation clinical study of CRB-701 is ...
The SEC currently has several notable rule proposals that have received public comment but have not yet been finalized. The potential direction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback